
|Articles|June 6, 2018
What every urologist needs to know about SpaceOAR® hydrogel
Advertisement
Study data has shown that SpaceOAR® hydrogel significantly improves quality of life for patients with prostate cancer who have undergone radiotherapy. But what does it take to implement this procedure into routine practice, and what can urologists expect regarding reimbursement?
In this supplement, practicing urologists will share perspectives on this procedure, addressing topics that include:
Advertorial Supported by:
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mark Tyson, MD shares promising BOND-003 results in papillary NMIBC
2
CORE-008: Cretostimogene achieves high CR rate in high-risk NMIBC
3
Gemcitabine intravesical system delivers high 12-month DFS in papillary-only NMIBC
4
Modern frameworks for treating high-risk non–muscle invasive bladder cancer
5

















